| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.9 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | 0.012 | 0.9 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | 0.013 | 0.9 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | 0.0053 | 0.9 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.9 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.0083 | 0.9 |
| mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | -0.005 | 0.9 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | 0.0058 | 0.9 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.0073 | 0.9 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.0067 | 0.9 |